Walleye Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Walleye Trading's ARKG Position: Q1 2026 in Review
Walleye Trading reduced its ARK Genomic Revolution ETF (ARKG) stake by 20% in Q1 2026, selling an estimated $523K and leaving 70,990 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1750.
Walleye Trading first reported a position in ARKG in Q3 2021 and has held it in 8 quarters since. The position peaked at $4M in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Walleye Trading held 70,990 shares of ARK Genomic Revolution ETF worth $1.88M as of Q1 2026.
- Walleye Trading sold 17,849 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $523K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #1750 holding.
- Walleye Trading first reported a position in ARK Genomic Revolution ETF in Q3 2021 and has held it in 8 quarters since.
- Walleye Trading's ARK Genomic Revolution ETF position peaked at $4M in Q4 2023.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.